410 results on '"Tortorella, Carla"'
Search Results
2. Unusual CLIPPERS presentation with a predominant spinal cord involvement: case report and review of the literature
3. Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders
4. Concurrent management of multiple sclerosis and natalizumab-induced hepatitis with ofatumumab: a case report
5. Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry
6. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
7. Correction to: Concurrent management of multiple sclerosis and natalizumab‑induced hepatitis with ofatumumab: a case report
8. Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World Studies
9. Dimethyl Fumarate or Teriflunomide for Relapsing–Remitting Multiple Sclerosis: A Meta-analysis of Post-marketing Studies
10. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
11. Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience
12. Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
13. Disability patterns in multiple sclerosis: a meta-analysis on PIRA and RAW in the real world context
14. Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies
15. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study
16. Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
17. Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies
18. Radiological Reporting Systems in Multiple Sclerosis.
19. Incidence and determinants of seizures in multiple sclerosis: a meta-analysis of randomised clinical trials.
20. Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria
21. Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy
22. Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis
23. Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study
24. Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
25. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
26. Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study
27. Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study
28. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
29. Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis
30. Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study
31. Non-alcoholic Wernicke encephalopathy presenting as bilateral hearing loss: a case report
32. Dimethyl fumarate or teriflunomide for relapsing-remitting multiple sclerosis: a meta-analysis of post-marketing studies
33. Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs
34. Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose
35. Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study
36. A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study
37. Stopping disease-modifying treatments in multiple sclerosis: a meta-analysis with meta-regression
38. “Better explanations” in multiple sclerosis diagnostic workup: A 3-year longitudinal study
39. Pregnancy and antibody-mediated CNS disorders: What do we know and what should we know?
40. Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
41. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study
42. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks
43. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks
44. Induction treatment strategy in multiple sclerosis: a review of past experiences and future perspectives
45. Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis
46. Non-traumatic acute myelopathies: Clinical and imaging features in a real world emergency setting
47. Shift of multiple sclerosis onset towards older age
48. Early transient asymptomatic neutropenia associated with alemtuzumab treatment in multiple sclerosis: a case report
49. Progressive multifocal leukoencephalopathy after daratumumab in multiple myeloma: A case report
50. Digital work engagement among Italian neurologists
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.